GLAUKOS CORP
GKOS · NYSE
Updated at 2026-10-14 12:34:30
- Today's High
- $171.22
- Today’s Low
- $164.95
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $166.79
- Previous Close
- $168.02
- Volume
- 881.89K
- Market Cap
- $9.91B
- P/E Ratio
- --
- EPS
- $-3.26
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- MEDICAL DEVICES
- Headquarters
- ONE GLAUKOS WAY, ALISO VIEJO, CA, UNITED STATES, 92656
- Country
- US
- Listing Date
- 2015-06-25
- Fiscal Year End
- December
- Shares Outstanding
- 58.98M
- CIK
- 0001192448
- Website
- www.glaukos.com
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, is focused on developing new therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is headquartered in San Clemente, California.
Financial Metrics
Revenue
2026-06-30
$185.61M
2026-03-31
$150.57M
2025-12-31
$143.12M
2025-09-30
$133.53M
Operating Expenses
2026-06-30
$168.86M
2026-03-31
$137.08M
2025-12-31
$138.35M
2025-09-30
$121.07M
Net Income
2026-06-30
-$18.37M
2026-03-31
-$19.78M
2025-12-31
-$133.65M
2025-09-30
-$16.23M
Net Profit Margin
2026-06-30
-9.9%
2026-03-31
-13.13%
2025-12-31
-93.38%
2025-09-30
-12.15%
Earnings Per Share
2026-06-30
$-0.14
2026-03-31
$-0.18
2025-12-31
$-0.90
2025-09-30
$-0.16
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$5.62M
2026-03-31
-$5.29M
2025-12-31
-$125.44M
2025-09-30
-$4.63M
Effective Tax Rate
2026-06-30
-3.7%
2026-03-31
-2.5%
2025-12-31
4.4%
2025-09-30
-1.46%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $185.61M | $150.57M | $143.12M | $133.53M |
| Operating Expenses | $168.86M | $137.08M | $138.35M | $121.07M |
| Net Income | -$18.37M | -$19.78M | -$133.65M | -$16.23M |
| Net Profit Margin | -9.9% | -13.13% | -93.38% | -12.15% |
| Earnings Per Share | $-0.14 | $-0.18 | $-0.90 | $-0.16 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$5.62M | -$5.29M | -$125.44M | -$4.63M |
| Effective Tax Rate | -3.7% | -2.5% | 4.4% | -1.46% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.